Cite
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer.
MLA
Geyer, Charles E., et al. “Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer.” New England Journal of Medicine, vol. 355, no. 26, Dec. 2006, pp. 2733–43. EBSCOhost, https://doi.org/10.1056/NEJMoa064320.
APA
Geyer, C. E., Forster, J., Lindquist, D., Chan, S., Romieu, C. G., Pienkowski, T., Jagiello-Gruszfeld, A., Crown, J., Chan, A., Kaufman, B., Skarlos, D., Campone, M., Davidson, N., Berger, M., Oliva, C., Rubin, S. D., Stein, S., & Cameron, D. (2006). Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer. New England Journal of Medicine, 355(26), 2733–2743. https://doi.org/10.1056/NEJMoa064320
Chicago
Geyer, Charles E., John Forster, Deborah Lindquist, Stephen Chan, C. Gilles Romieu, Tadeusz Pienkowski, Agnieszka Jagiello-Gruszfeld, et al. 2006. “Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer.” New England Journal of Medicine 355 (26): 2733–43. doi:10.1056/NEJMoa064320.